代谢综合征亡:疾病影响和治疗向
Jiaenli Bolati1, Ahequeli Gemingnuer1, Fang Lu1
1School of Pharmacy, Heilongjiang University of Chinese Medicine, No.24 Heping Road, Harbin, 150040, P. R. China.
Journal of physiology and biochemistry
|February 27, 2026
概括
死细胞亡,一个调节的细胞死亡,通过炎症和胰岛素抵抗驱动代谢综合征 (MetS). 针对这个过程为MetS提供了潜在的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 代谢疾病 代谢疾病
- 免疫学 免疫学 免疫学
背景情况:
- 亡是一种受调节的细胞死亡形式,涉及RIPK激活和体形成.
- 新出现的证据将死细胞灭绝与代谢综合征 (MetS) 病原发生联系起来,包括炎症和胰岛素抵抗.
- RIPK1-RIPK3-MLKL通路与关键代谢组织内的亡有关.
研究的目的:
- 系统地审查死细胞灭绝在MetS中的机械作用.
- 综合有关亡生物标志物的证据及其在MetS中的相关性.
- 讨论针对MetS和它们的翻译挑战的死症的治疗策略.
主要方法:
- 关于死和MetS的实验研究的文献综述.
- 分子机制,生物标志物数据和治疗干预的分析.
- 机理学和翻译视角的整合.
主要成果:
- 尸体亡通过骨肌肉,肝脏,脂肪组织和胰腺β细胞的炎症和功能障碍导致MetS.
- RIPK1-RIPK3-MLKL轴是MetS中亡的关键调解者.
- 潜在的诊断,预后和治疗生物标志物正在出现,这些生物标志物与亡相关.
结论:
- 死体亡在代谢综合征的进展中起着重要作用.
- 向死细胞亡是一个有前途的治疗途径,用于 MetS.
- 需要进行进一步的研究,以解决死灭机制和MetS治疗翻译方面的知识差距.
相关概念视频
Necrosis
6.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.9K
Overview of Cell Death
10.6K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.6K
Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Autophagic Cell Death
4.8K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Electron Transport Chain: Complex I and II
19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.3K


